Longview Acquisition Corp. II, trading under the ticker LGV, is a blank-check company sponsored by Glenview Capital Management, the healthcare-focused hedge fund led by Larry Robbins. The vehicle completed its initial public offering in 2021 targeting the healthcare and life sciences sector, following the earlier Longview Acquisition Corp., which merged with medical-imaging company Butterfly Network. LGV's 10-Q filed May 16, 2022, under accession number 0001410578-22-001618, reflected the company in its active search phase for a qualifying business combination target. The SPAC ultimately did not complete a merger and moved toward liquidation. For the full filing history, timeline, and sponsor profile on LGV, sign up for complete data access at SpacDesk.